HeartFlow’s current products are HeartFlow Plaque analysis, which aims to provide clinicians with the ability to more ...

Heartflow, a company involved in AI technology for coronary artery disease, went public on Friday under the ticker symbol HTFL, raising $316.7 million with its initial public offering. Late last week, ...